Abstract
Oral dapagliflozin (Edistride (R), Forxiga (R)) is approved in the EU at a dosage of 5 mg/day as an adjunct to insulin in adults with type 1 diabetes ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
